Statements (13)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:clinicalTrialPhase |
Phase 1/2
|
gptkbp:developedBy |
gptkb:Relay_Therapeutics
|
https://www.w3.org/2000/01/rdf-schema#label |
RLY-4008
|
gptkbp:indication |
cholangiocarcinoma
solid tumors with FGFR2 alterations |
gptkbp:intendedUse |
gptkb:cancer
|
gptkbp:mechanismOfAction |
FGFR2 inhibitor
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:status |
investigational
|
gptkbp:target |
gptkb:FGFR2
|
gptkbp:bfsParent |
gptkb:Relay_Therapeutics
|
gptkbp:bfsLayer |
6
|